Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2003
04/01/2003US6541623 Sepsis shock therapy; rheumatic diseases; antiinflammatory agents; nucleotide sequence detector
04/01/2003US6541616 Exterior membrane; nucleotide sequence; induction immunology response
04/01/2003US6541612 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation
04/01/2003US6541611 Prevent immunology response
04/01/2003US6541605 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
04/01/2003US6541457 Mammalian IAP gene family, primers, probes and detection methods
04/01/2003US6541259 Nucleic acid sequences to proteins involved in isoprenoid synthesis
04/01/2003US6541258 AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectors
04/01/2003US6541257 Method for preparing barley green regenerative tissue
04/01/2003US6541256 Growth medium for human corneal endothelial cells
04/01/2003US6541255 Engraftable human neural stem cells
04/01/2003US6541254 Glycosylation variants of iduronate 2-sulfatase
04/01/2003US6541253 Diagnostics and therapy of diseases associated with HHV-8 infections
04/01/2003US6541250 Preferential aggregation; for use in the treatment of melanomas
04/01/2003US6541249 Nutrient broth for use in the culture of stem cells and generation of cytokines
04/01/2003US6541247 Dissociating central nervous system tissue from animal and screening for cells expressing Notch1 receptor; can use to stimulate generation of new neurons or glial cells; drug screening
04/01/2003US6541245 Adenoviral helper vectors
04/01/2003US6541233 β-glucanase from a bacillus
04/01/2003US6541225 Methods and compositions for generating human monoclonal antibodies
04/01/2003US6541223 Propagating permissive eukaryotic cells, transiently stressing to increase production of protein, introducing virus stock, incubating, then harvesting viral agent; vaccines, diagnostic assay
04/01/2003US6541221 For the identification, isolation, and/or expression of genes undiscoverable by current methods; use to isolate nucleic acids coding for proteins, including transmembrane proteins, and in research of human diseases and development
04/01/2003US6541220 Novel parathyroid hormone (PTH), parathyroid hormone related protein (PTHrP), receptors (PTH1R and PTH3R) isolated from zebrafish; vectors, host cells, recombinant methods for producing; use in identifying receptor agonists, antagonists
04/01/2003US6541219 Therapeutic Gene
04/01/2003US6541036 Placing tumor cells in culture in vitro or ex vivo supplemented with pro-apoptotic agent, transferring tumor cells into diffusion chamber, inserting chamber into human for therapeutically effective time
04/01/2003US6541028 Methods for promoting healing of corneal resurfacing wounds
04/01/2003US6541024 Regeneration and augmentation of bone using mesenchymal stem cells
04/01/2003US6541023 Support for tissue engineering contains a collagen membrane such as a compressed collagen sponge, and the porous matrix is covered on atleast one side with collagen membrane
04/01/2003US6541022 Mineral and cellular patterning on biomaterial surfaces
04/01/2003US6541012 System for the production of AAV vectors
04/01/2003US6541010 Alphavirus RNA replicon systems
04/01/2003US6541008 Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof
04/01/2003US6541003 An immunizing formulation comprising a plasmid encoding an attenuated, doxycycline-inducible proviral molecular clone of the human immunodeficiency virus type 1, and a pharmaceutical carrier
04/01/2003US6540994 Administering to a cancer patient, a macrophase produced by culturing monocytes in vitro, and macrophages having specific properties, such as, cytotoxic acitivity without IFN-gamma is increased by 20-30% with respect to standard macrophages
04/01/2003CA2102129C Growth hormone antagonists
04/01/2003CA1341426C Process for the manufacture of thrombin inhibitors
03/2003
03/27/2003WO2003029411A2 Novel cyclooxygenase variants and methods of use
03/27/2003WO2003025542A2 Immune response associated proteins
03/27/2003WO2003025220A2 Fusion proteins useful for detecting analytes
03/27/2003WO2003025211A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003WO2003025210A1 Use of hcv core antigen assay for screening of anti-viral compounds
03/27/2003WO2003025209A1 Use of hcv core antigen assay for screening of anti-viral compounds
03/27/2003WO2003025193A1 Plant enzymes for bioconversion
03/27/2003WO2003025191A2 Pseudotyped retroviral vector system
03/27/2003WO2003025189A2 A packaging complementation cell-line for sv-40 vectors
03/27/2003WO2003025183A2 Random integration of a polynucleotide after in vivo linearization
03/27/2003WO2003025169A2 Nucleic acid for cloning vector
03/27/2003WO2003025167A2 Cultured stromal cells and uses thereof
03/27/2003WO2003025164A2 A gene encoding cyclododecanone monooxygenase
03/27/2003WO2003025163A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
03/27/2003WO2003025160A2 Neuron culture medium and use of cholesterol for cultivating, differentiating or proliferating neurons
03/27/2003WO2003025157A1 A coculture system to identify proteins triggering redifferentiation of tumor cells
03/27/2003WO2003025151A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
03/27/2003WO2003025150A2 Lipid-associated molecules
03/27/2003WO2003025149A2 Cell populations which co-express cd49c and cd90
03/27/2003WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003WO2003025138A2 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003WO2003025134A2 mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
03/27/2003WO2003025132A2 Dna polymerases and mutants thereof
03/27/2003WO2003025131A2 Protein modification and maintenance molecules
03/27/2003WO2003025129A2 Neurotransmission-associated proteins
03/27/2003WO2003025126A2 Compositions and methods for t cell priming and immunotherapy
03/27/2003WO2003025117A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/27/2003WO2003025116A2 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production
03/27/2003WO2003025018A2 Dimeric and multimeric antigen binding structure
03/27/2003WO2003025015A2 A soluble toll-like receptor
03/27/2003WO2003025013A1 Asparagine hydroxylation of the cad domain of a hif protein
03/27/2003WO2003025011A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method
03/27/2003WO2003024992A2 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
03/27/2003WO2003024989A2 Activation and expansion of cells
03/27/2003WO2003024988A1 Antisense modulation of nac expression
03/27/2003WO2003024473A2 Retinoid receptor pan-antagonists for stimulating chondrogenesis
03/27/2003WO2003024472A2 Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof
03/27/2003WO2003024471A2 Effect of growth hormone and igf-1 on neural stem cells and therapeutic application
03/27/2003WO2003024469A1 New antitumor agent
03/27/2003WO2003024463A1 Stratified cartilage tissue and methods to engineer same
03/27/2003WO2003024462A1 Cardiac transplantation of stem cells for the treatment of heart failure
03/27/2003WO2003024406A2 Nestin-expressing hair follicle stem cells
03/27/2003WO2003024404A2 Chemokines as adjuvants of immune response
03/27/2003WO2003024393A2 Autologous t-cell vaccines materials and method
03/27/2003WO2003024312A2 Cell therapy system
03/27/2003WO2003024297A2 Cell storage and delivery system
03/27/2003WO2003024215A1 Preservation of non embryonic cells from non hematopoietic tissues
03/27/2003WO2003024200A2 Production of transgenic birds using stage x primordial germ cells
03/27/2003WO2003024191A2 Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof
03/27/2003WO2003000843A3 P53 binding protein-related protein in cardiomyopathy
03/27/2003WO2002098889A3 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
03/27/2003WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use
03/27/2003WO2002092054A3 Immune modulation device for use in animals
03/27/2003WO2002088330A8 Neural progenitor cells
03/27/2003WO2002083888A3 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
03/27/2003WO2002083870A3 Pufa polyketide synthase systems and uses thereof
03/27/2003WO2002078607A3 Mucin peptide with immunoenhancing properties
03/27/2003WO2002070717A3 Nitrile hydratase and a method for producing amides
03/27/2003WO2002068927A3 Using viruses to detect or purify proteins
03/27/2003WO2002059291A3 Biological organism for preparing pharmaceutical compositions for treating mammals
03/27/2003WO2002055992A3 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
03/27/2003WO2002055544A3 Fibrin binding polypeptides useful inter alia in medical imaging processes
03/27/2003WO2002053761A3 Recombinant protective protein from $i(streptococcus pneumoniae)
03/27/2003WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/27/2003WO2002044377A3 Obp1:a protein selectively expressed in osteoblasts